Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

PURPOSE: To compare the treatment response and progression-free survival (PFS) in advanced hepatocellular carcinoma (HCC) patients who received sorafenib treatment either alone or combined with radioembolization (RE). METHODS: Follow-up images of the patients treated within a multicenter phase II tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Öcal, Osman, Schütte, Kerstin, Zech, Christoph J., Loewe, Christian, van Delden, Otto, Vandecaveye, Vincent, Verslype, Chris, Gebauer, Bernhard, Sengel, Christian, Bargellini, Irene, Iezzi, Roberto, Philipp, Alexander, Berg, Thomas, Klümpen, Heinz J., Benckert, Julia, Pech, Maciej, Gasbarrini, Antonio, Amthauer, Holger, Bartenstein, Peter, Sangro, Bruno, Malfertheiner, Peter, Ricke, Jens, Seidensticker, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606085/
https://www.ncbi.nlm.nih.gov/pubmed/35916920
http://dx.doi.org/10.1007/s00259-022-05920-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606085/
https://www.ncbi.nlm.nih.gov/pubmed/35916920
http://dx.doi.org/10.1007/s00259-022-05920-8

Ejemplares similares